Senior Scientist II, Toxicologist

BioSpace; San Rafael (CA); On-site; USD 120,000 - 180,000; Full time

Job summary

BioMarin is seeking a Senior Scientist 2 in the Pharmacology and Toxicology group to provide nonclinical pharmacology/toxicology leadership across drug development. You will design, implement, and interpret studies for small molecules and biologics while aligning with GLP standards and regulatory expectations.

The role involves collaboration with internal and external teams, preparation of regulatory documents, and active participation in cross-functional development pathways to support clinical

Qualifications

• Ph.D. in toxicology, pharmacology, or related field.
• 5+ years of equivalent industry experience for a Scientist level.
• Strong knowledge of GLP and drug development processes.
• Experience supporting small molecules or biologics development.
• Experience preparing regulatory submissions and communicating with health authorities desirable.
• Excellent written and verbal communication and cross-functional collaboration.

Responsibilities

• Develop nonclinical pharmacology/toxicology strategies across development stages.
• Design, execute, and interpret nonclinical studies in small molecules or biologics.
• Prepare synopses, protocols, study reports, and regulatory documents.
• Coordinate with CROs, labs, partners, and internal teams.
• Present data to regulatory bodies and cross-functional teams.

Skills

Pharmacology

Toxicology

GLP knowledge

Data interpretation

Education

PhD in Toxicology/Pharmacology

Board Certification in Toxicology (preferred)

Job description

Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions. Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

About Worldwide Research And Development

From research and discovery to post-market clinical development, our R&D engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with rare diseases.

The Pharmacology and Toxicology Department at BioMarin is seeking a Senior Scientist 2 to provide nonclinical pharmacology and toxicology expertise for the development of BioMarin’s small molecule and biologic drug candidates. This individual will provide scientific leadership and play a pivotal role providing nonclinical expertise in support of all phases of the drug development process from late-stage research through market application and commercialization. A successful candidate will contribute to the strategic development of BioMarin’s therapeutics by creating a best-evidence synthesis of existing knowledge and by designing, implementing, interpreting, investigating and reporting data that elucidates the pharmacologic/toxicologic profile of drug candidates. This individual will work collaboratively with internal and external cross-functional subteams, collaborators and consultants to contribute to integrated development pathways including regulatory submissions throughout the drug development cycle. Comprehensive analysis and interpretations of these studies are reported and defended to regulatory agencies in meetings and documents such as briefing documents, IND/CTA, annual updates, investigator brochures, special protocol assessments and market applications. The successful candidate will have a pharmacology/toxicology background as well as a strong understanding of Good Laboratory Practices (GLPs) and will provide broad-based support to align nonclinical efforts with the company’s opportunistic philosophy of drug development. The candidate will interact with scientists across the company in order to provide a balanced assessment as to the risk/benefit profile associated with a drug candidate’s advancement. The individual will be responsible for the planning, implementation and organization of nonclinical studies along with the use of drug exposure to bridge across species, presentation of data (written and verbal) to cross-functional core teams and subteams, external collaborators, and the scientific community. This individual will actively participate in representing Pharmacological Sciences on cross-functional project teams and/or lead project subteams.

Responsibilities

• Contribute to and implement an overall drug development strategy to support nonclinical and clinical pharmacology development during all stages of drug development
• Design, implement, report and interpret nonclinical study data of small molecule, biologic or other novel drug candidate constructs
• Prepare study synopses, protocols, study reports and regulatory documents to support nonclinical development of BioMarin’s drug candidates
• Interact/collaborate with various BioMarin functions, CROs, university or analytical laboratories, business partners, as necessary to ensure appropriate/timely progression of BioMarin projects
• Effectively communicate nonclinical findings and their relevance to senior management, project teams, collaborators, and regulatory agencies (i.e. FDA, EMEA, MHRA, ROW)
• Participate in multi-disciplinary drug development teams and may lead sub-teams
• Excellent written and verbal communication skills
• Ability to build/foster productive cross-functional collaborations both within and external to BioMarin.

Education

• Required: Doctorate (Ph.D.) or equivalent experience in toxicology, pharmacology or a related, relevant discipline.
• Board Certification in Toxicology is highly preferred.

Experience

• Nonclinical pharmacology/toxicology background and 5+ years industry experience in the pharmaceutical, CRO, and/or biotechnology field for a Scientist level.
• Strong understanding of drug development and regulatory process, as well as a strong understanding of Good Laboratory Practices (GLPs)
• Experience supporting the development of small molecules, biologics and/or other therapies, including determining non-clinical program strategy and design.
• Experience with the preparation of regulatory submissions (IND/CTDs, NDA/BLA, etc.) and communicating/interacting with health authorities desirable
• Experience in the design, conduct, and interpretation of GLP and non-GLP nonclinical toxicology studies
• Strong critical, scientific, and strategic thinking skills; Strong problem solving and decision making abilities
• Strong communication (verbal and written) skills
• Experience and ability to work collaboratively in cross-functional teams

Workstyle

While we are open to this role being conducted virtual there is a strong preference for candidates who are open to relocating to the Bay Area via our program.

Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

Ireland Safety Responsibility

Support the organisation’s commitment to environmental protection, injury prevention, and continual improvement of EHS management systems. Actively contribute to a safe and environmentally responsible workplace by identifying hazards, reporting incidents and participating in EHS initiatives and training.